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Summary – A growing body of evidence suggests that host genetic factors play an important role both in 
susceptibility to human immunodeficiency virus 1 (HIV-1) infection and in progression to AIDS. Interleukin 18 
(IL-18) is a pleiotropic proinflammatory cytokine that serves as an important regulator of immune responses. It 
plays a key role in induction of both Th1 and Th2 cytokines and, thereby, modulates their immune responses. 
Single nucleotide polymorphisms in the IL-18 gene promoter region may lead to an altered transcriptional 
activity and IL-18 production, and so this may account for individuals’ variation to the risk of HIV-1 infection. 
With this perspective, the -137G/C polymorphism in the promoter region of the IL-18 gene was studied in 500 
patients with HIV-1/AIDS and an equal number of sex and age matched healthy controls using sequence specific 
polymerase chain reaction analysis. We did not observe any significant association of the heterozygous G/C 
genotype with the risk of HIV-1-infection/AIDS. However, statistically significant associations of the G allele 
and homozygous G/G genotype of -137 G/C polymorphism of IL-18 promoter with increased risk of HIV-1/
AIDS were identified. The data of the present study suggest that IL-18 -137 G allele and G/G genotype seem to 
be involved in the pathogenesis of HIV-1 infection among North Indians.
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Introduction
The susceptibility and clinical manifestations of infectious 
diseases in human populations are influenced by a variety of 
factors. Among these, host genetic variability plays a major 
role in determining individuals’ susceptibility to potentially 
pathogenic infections and subsequent disease severity (Segal 
and Hill, 2003). In the context of HIV-1 infection, genetic 
epidemiologic cohort studies have shown polymorphisms 
in the genes encoding chemokine receptors to be associated 
with the resistance against acquiring HIV-1 infection and 
an altered rate of disease progression in infected individu-
als (O’Brien and Moore, 2000). Moreover, several human 
leukocyte antigen (HLA) alleles have also been associated 
with different rates of progression and varying susceptibility 
to HIV infection (Smith et al., 1997; Klein et al., 1998).
Single nucleotide polymorphism (SNP) in genes encoding 
cytokines and their receptors have been shown to influence 
not only cytokine gene expression, but also susceptibility to 
or progress of the disease (Bidwell et al., 2001; Kaur et al., 
2007). IL-18 gene encoding human interleukin 18 (IL-18) 
cytokine is mapped to chromosome 11q22.2–22.3 (Nolan et 
al., 1998) and within this gene three SNPs in the promoter 
region have been identified. Of these, polymorphisms at 
promoter positions -137 and -607 influence the activity and 
expression of IL-18 gene. The G to C substitution at the posi-
tion -137 abolishes the human histone 4 transcription factor 
1 (H4TF-1) nuclear factor-binding site and the C to A substi-
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tution at position-607 disrupts the binding sites of a potential 
cAMP responsive element binding protein (CREB) thereby, 
reducing its transcription. Therefore, mutations at these two 
IL-18 promoter polymorphisms (-607C/A and -137G/C) 
and their haplotypes seem to account for differential IL-18 
expression and changes in the production of this cytokine 
(Giedraitis et al., 2001).
IL-18 is a pleiotropic proinflammatory cytokine that is 
recognized as an important regulator of innate and acquired 
immune responses (Dinarello and Fantuzzi, 2003). It is pro-
duced mainly by monocytes/macrophages, but also other 
immune and non-immune cells (Gracie et al., 2003; Skurk 
et al., 2005). By virtue of its nature, IL-18 plays a key role 
in induction of both Th1 and Th2 cytokines and, thereby, 
modulates their immune responses. IL-18 has been shown 
to play a protective role in the host defense towards different 
sources of infection or to have a pathological role in various 
inflammatory and autoimmune diseases (Nakanishi et al., 
2001). In the context of HIV-1 infection, IL-18 has also been 
shown to play a pathogenic role by enhancing viral replica-
tion in both monocytes and T-cells (Shapiro et al., 1998; 
Klein et al., 2000). Moreover, clinical studies have demon-
strated the involvement of IL-18 in the immunopathogenesis 
of HIV-1 infection (Torre et al., 2000; Wiercinska-Drapalo 
et al., 2004); however, most of the reports of such studies so 
far have focused primarily on associating the serum level 
of IL-18 and its clinical outcome with the pathogenesis of 
HIV-1 infection. Thus, it is believed that SNP studies may 
provide valuable information about the correlation of this 
noble cytokine gene with HIV-1 /AIDS. For this reason, the 
present study was aimed to see the impact of polymorphisms 
of the IL-18 gene promoter -137 (G/C) position on the risk 
and progression of HIV-1 infection. 
To the best our knowledge, no report on the association 
of any SNP of the IL-18 gene with HIV-1/AIDS is available 
in the literature. This is therefore the first association study 
of IL-18 among North Indian HIV-1/AIDS patients. 
Materials and Methods
Materials. A total of 500 seropositive HIV-1 /AIDS patients and 
an equal number of age and gender matched seronegative healthy 
controls were recruited from the Immunodeficiency Clinic of 
the Department of Internal Medicine, Postgraduate Institute of 
Medical Education and Research (PGIMER) Chandigarh, India. 
After obtaining informed consent, 2–3 ml of peripheral blood was 
drawn from the study subjects as well as controls and collected in 
EDTA-coated tubes. 
Methods. Genomic DNA of each subject was extracted from 
peripheral blood leukocytes by SDS lysis and proteinase K digestion 
followed by standard phenol-chloroform method described by Sam-
brook et al. (1989). Genotyping of IL-18-137 G/C polymorphisms 
was performed by Sequence Specific Polymerase Chain Reaction 
analysis using the same oligonucleotide primers and conditions 
reported previously (Giedraitis et al., 2001). 
Statistical analysis. For statistical analysis of the data, SPSS soft-
ware, version 11.5 (SPSS Inc., Chicago, IL) for Windows was used. 
The Hardy-Weinberg equilibrium between expected and observed 
genotype distributions was determined by means of the Chi-square 
(χ2) test. Odds ratios (ORs) with 95% confidence intervals (95% 
CIs) were calculated according to Epi Info Version 3.5.1 2008; CDC, 
Atlanta, GA, USA.
Results
A total of 500 patients with HIV-1/AIDS infection and 
an equal number of healthy controls were studied. Although 
males appeared more frequent in both cases and controls 
than females, there was no significant difference between 
cases and controls in gender distribution (65.2% versus 
63.4% male and 34.6% versus 36.6% female (P >0.05). The 
mean age (± standard deviation, years) was 35.4 (±7.9 years) 
for cases and 36.2 (± 9.8) years for controls. There was no 
significant mean age difference between the cases and the 
controls (P >0.05).
In this case-control study, the functional SNP in the pro-
moter region of IL-18 at the position -137 was genotyped 
and its association with HIV-1/AIDS infection among North 
Indian population was analyzed. The genotype distributions 
and allele frequencies of the two study groups and the statisti-
cal comparisons of these data are presented in Table 1. The 
relative distributions of the G/G, G/C, and C/C genotypes 
at the position -137 were 176 (35.2%), 301 (60.2%) and 
23 (4.6%) in HIV-1 patients, respectively, while in healthy 
control subjects these were 135 (27.0%), 327 (65.4%) and 38 
(7.6%), respectively. Furthermore, the frequency of G and C 
alleles were 653 (65.3%) versus 598 (59.8%) and 347 (34.7%) 
versus 402 (40.2%) in cases and controls respectively. The 
-137 G/G genotype was significantly over-represented in 
the HIV-1 patients than in healthy controls (P < 0.05) and 
it was associated with an increased risk of HIV-1 infection. 
Table 1. IL-18 promoter -137 G/C polymorphism distribution  
in the groups






C allele 347(34.7%) 402(40.2%)
G allele 653(65.3%)* 598(59.8%)*
*Significant differences between groups.
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Moreover, the frequency of the G allele was significantly 
higher in cases than in healthy controls (P < 0.05). On the 
other hand, no considerable difference in the frequency of 
heterozygote -137 G/C genotype was observed in the two 
study groups (P >0.05). 
Discussion 
The pathogenesis of HIV-1 infection is generally char-
acterized by a long-term, chronic disease that gradually 
progresses to AIDS. However, the rate of disease progression 
is substantially different among HIV-1-infected individuals 
(Shioda and Nakayama, 2006). A small fraction of HIV-1-
infected individuals remain clinically and immunologically 
healthy for more than ten years after seroconversion. On 
the contrary, the disease of another significant fraction of 
patients is characterized by extremely rapid progression 
within a period as short as 1 year. There is still another 
group of individuals, who do not get infected even after 
repeated exposures (Fauci and Pantaleo, 1996; Shioda and 
Nakayama, 2006). Host genetic variability plays a major role 
in determining individual susceptibility or resistance to the 
infection with HIV-1, as well as the subsequent rate of disease 
progression to AIDS following infection. Polymorphisms in 
chemokine receptors that serve as HIV-1 coreceptors or in 
their natural ligands have been associated with susceptibil-
ity to infection as well as rates of disease progression (Smith 
et al., 1997; O’Brien and Moore, 2000). Furthermore, HLA 
alleles and closely related genes on MHC have also been 
suggested to influence HIV-1 disease progression (Klein et 
al., 1998).
IL-18 is a pleiotropic proinflammatory cytokine with 
effects on both innate and acquired immune responses 
(Dinarello and Fantuzzi, 2003). It has been shown to play 
a protective role in host defense towards different sources 
of infection or to have a pathological role in various inflam-
matory and autoimmune diseases (Nakanishi et al., 2001). 
As to the effect of IL-18 on HIV-1 infection and disease 
progression, IL-18 has been shown to enhance the HIV-1 
replication in acutely or chronically infected human mono-
cytic and T-cell lines with an intermediate role of HIV-1 
inductive TNF-α and IL-6, suggesting a role for IL-18 in 
HIV-1 pathogenesis (Shapiro et al., 1998; Klein et al., 2000; 
Pugliese et al., 2002). Moreover, a report by Stylianou et al. 
(2003) has revealed the involvement of IL-18 in enhancing 
the expression of the HIV-1 co- receptor CXCR4 in periph-
eral blood mononuclear cells from HIV-1-infected patients. 
Such upregulation of CXCR4 in turn seems to facilitate 
viral entry and replication and could possibly contribute to 
the disease progression (Stylianou et al., 2003). They also 
indicated that IL-18 is not only one of the several inflam-
mation markers that increases during HIV-1 infection, but 
may also be involved in the pathogenesis of this disease. 
Increased IL-18 concentrations in the serum of HIV-1-
infected patients are likely to play an important role in the 
development and progression of the infection towards AIDS 
and the associated clinical conditions (Iannello et al., 2009). 
Apart from these studies, Wiercinska-Drapalo et al. (2004) 
also demonstrated the presence of an association between 
plasma level of IL-18, the viral load and disease progression 
in HIV-1-infected patients. In another instance, Song et al. 
(2006) further demonstrated the presence of overall posi-
tive correlation between serum IL-18 and HIV-1 viral load 
accompanied by negative correlation between serum IL-18 
and CD4 + T-cell count. 
In the current study, five hundred HIV-1 patients and an 
equal number of healthy control subjects were genotyped 
for IL-18 -137 G/C promoter polymorphism in order to 
assess possible association with the risk of HIV-1 infection 
among North Indians. The results of this study demonstrated 
a statistically significant association between the -137 G al-
lele and G/G genotype (high IL-18 producer) and the risk of 
HIV-1/AIDS, however, no significant association between 
the -137 G/C heterozygous genotype and HIV-1/AIDS risk 
was detected. The findings of the current study are partially 
consistent with those of Segat et al. (2006), who found -137 
G/G genotype at relatively higher frequency, whereas -137 
C/C genotype at almost two-fold lower frequency in HIV-1 
positive groups than in healthy control subjects. 
Elevated protein levels could frequently be the conse-
quence of functional polymorphisms within genes and regu-
latory regions of genes. These changes in proteins expression 
levels may influence clinical course of diseases. IL-18 -137 
G/C promoter polymorphism has been demonstrated to in-
fluence the transcriptional activity of the gene and hence may 
account for observed cytokine level variations. The G allele 
(G/G genotype) at the position -137 has been associated with 
higher transcription activity and higher IL-18 production 
(Giedraitis et al., 2001). An elevated cytokine level in the se-
rum in turn may enhance viral replication and subsequently 
influence the rate of disease progression. Hence, the disease 
of HIV-1 patients with the -137 G allele and G/G genotype 
may progress to AIDS faster than the disease of those with 
the -137 C/C genotype. Therefore, we believe that this could 
explain the results of the present study.
In summary, the data of current study demonstrate that 
the G allele and G/G genotype at the position -137 of the IL-18 
gene promoter polymorphism could have a role in HIV-1 
disease development. This finding may provide further 
evidence in elucidating the role of host genetic variations 
in the immunopathogenesis of HIV-1 infection. However, 
this finding needs to be further confirmed in another study 
correlating IL-18 gene promoter polymorphisms and serum 
levels of IL-18 in HIV-1/AIDS patients for precise determina-
tion of the role IL-18 in HIV-1 infection.
